These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 3142034)
1. Pelvic lymphadenectomy as staging before definitive treatment of prostatic carcinoma. Elfving P; Lundgren R Scand J Urol Nephrol Suppl; 1988; 110():155-61. PubMed ID: 3142034 [TBL] [Abstract][Full Text] [Related]
2. [Prognosis of the patients with prostate cancer clinically confined within the pelvis]. Akimoto S; Masai M; Isaka S; Shimazaki J; Murakami S; Igarashi T Hinyokika Kiyo; 1990 Sep; 36(9):1039-45. PubMed ID: 2239609 [TBL] [Abstract][Full Text] [Related]
3. Radical excision of adenocarcinoma of prostate with pelvic lymph node involvement: surgical gesture or curative procedure. Utz DC Urology; 1984 Nov; 24(5 Suppl):4-11. PubMed ID: 6495469 [TBL] [Abstract][Full Text] [Related]
4. [Locoregional staging of prostatic neoplasms by extemporaneous histological examination of pelvic lymph nodes]. Zattoni F; Pegoraro V; Guazzieri S; Dal Bianco M J Urol (Paris); 1985; 91(3):155-6. PubMed ID: 4045210 [TBL] [Abstract][Full Text] [Related]
5. [Staging pelvic lymphadenectomy for carcinoma of the prostate]. Rinsho K; Ishikawa S; Nemoto R; Koiso K; Takeshima H; Uchida K Hinyokika Kiyo; 1985 Sep; 31(9):1583-7. PubMed ID: 4083215 [TBL] [Abstract][Full Text] [Related]
7. [Prostatic adenocarcinoma: nodal involvement and prognosis of stage D1 patients]. Arai Y; Oishi K; Okada K; Yoshida O; Kihara Y; Okuno H Hinyokika Kiyo; 1989 Jun; 35(6):981-6. PubMed ID: 2801398 [TBL] [Abstract][Full Text] [Related]
8. Staging lymphadenectomy should not be an antecedent to treatment in localized prostatic carcinoma. Paulson DF Urology; 1985 Feb; 25(2 Suppl):7-14. PubMed ID: 3969766 [TBL] [Abstract][Full Text] [Related]
9. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. Heidenreich A; Varga Z; Von Knobloch R J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387 [TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184 [TBL] [Abstract][Full Text] [Related]
11. Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy. Cadeddu JA; Partin AW; Epstein JI; Walsh PC Urology; 1997 Aug; 50(2):251-5. PubMed ID: 9255297 [TBL] [Abstract][Full Text] [Related]
12. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer]. Heidenreich A; Ohlmann CH Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337 [TBL] [Abstract][Full Text] [Related]
13. [Present status and questions on early prostatic cancer (stage A, B)]. Oishi K; Arai Y; Takeuchi H; Yoshida O Hinyokika Kiyo; 1991 Aug; 37(8):789-93. PubMed ID: 1957722 [TBL] [Abstract][Full Text] [Related]
14. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy. Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707 [TBL] [Abstract][Full Text] [Related]
15. Value of and indications for pelvic lymph node dissection in the staging of prostate cancer. Middleton RG NCI Monogr; 1988; (7):41-3. PubMed ID: 3173502 [TBL] [Abstract][Full Text] [Related]
16. Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer. Abdollah F; Sun M; Thuret R; Jeldres C; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI Int J Urol; 2012 Jul; 19(7):645-51. PubMed ID: 22416788 [TBL] [Abstract][Full Text] [Related]
17. Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients. Cozzarini C; Bolognesi A; Ceresoli GL; Fiorino C; Rossa A; Bertini R; Colombo R; Da Pozzo L; Montorsi F; Roscigno M; Calandrino R; Rigatti P; Villa E Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):674-83. PubMed ID: 15183470 [TBL] [Abstract][Full Text] [Related]
18. Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study. Edelstein RA; Zietman AL; de las Morenas A; Krane RJ; Babayan RK; Dallow KC; Traish A; Moreland RB Urology; 1996 Mar; 47(3):370-5. PubMed ID: 8633404 [TBL] [Abstract][Full Text] [Related]
19. [Clinical outcome of radical prostatectomy and pelvic lymph node dissection]. Mizutani K; Ono Y; Kato N; Takeda A; Yamada S; Kinukawa T; Hattori R; Sahashi M; Matsuura O; Takeuchi N Hinyokika Kiyo; 1995 Nov; 41(11):867-71. PubMed ID: 8533688 [TBL] [Abstract][Full Text] [Related]
20. Morbidity of pelvic lymphadenectomy, radical retropubic prostatectomy and external radiotherapy in patients with localised prostatic cancer. Bratt O; Elfving P; Flodgren P; Lundgren R Scand J Urol Nephrol; 1994 Sep; 28(3):265-71. PubMed ID: 7817168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]